Covered recipient · General Payments record
GIL M FERNANDEZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,539.23
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $321.86 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $176.62 | 9 |
| Acerta Pharma LLC | $43.96 | 2 |
| Astellas Pharma US Inc | $28.84 | 1 |
| Amgen Inc. | $24.16 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.51 | 1 |
| Medtronic, Inc. | $14.17 | 1 |
| Lilly USA, LLC | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $24.16 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117250377 | CMS |
| Astellas Pharma US Inc | $28.84 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139288058 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.72 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104377873 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.24 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105611475 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.51 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086149661 | CMS |
| Lilly USA, LLC | $13.60 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987222 | CMS |
| Medtronic, Inc. | $14.17 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119453521 | CMS |
| Novo Nordisk Inc | $19.11 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097234095 | CMS |
| Novo Nordisk Inc | $22.50 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096935483 | CMS |
| Novo Nordisk Inc | $23.08 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096587847 | CMS |
| Novo Nordisk Inc | $18.66 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096597574 | CMS |
| Novo Nordisk Inc | $19.46 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096779816 | CMS |
| Novo Nordisk Inc | $21.54 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097475563 | CMS |
| Novo Nordisk Inc | $9.51 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097590912 | CMS |
| Novo Nordisk Inc | $9.53 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097469940 | CMS |
| Novo Nordisk Inc | $33.23 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097522237 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.